All Posts by

Nicole Fitzgerald

NDEWS awarded two administrative supplements

In July 2021, the NDEWS Coordinating Center was awarded two administrative supplements from the National Institute on Drug Abuse to expand our efforts to monitor new and emerging drug trends through two new initiatives: wastewater-based epidemiology and national Poison Control data. Led by Dr. Tara Sabo-Atwood, the wastewater-based epidemiology initiative…

Shifts in drug seizures in the United States during the COVID-19 pandemic

A new analysis of law enforcement drug seizures in five key regions of the United States, led by NDEWS Co-Investigator Dr. Joseph Palamar, found an increase in methamphetamine and marijuana confiscations during the COVID-19 pandemic. Investigators examined trends in seizures of marijuana, cocaine, methamphetamine, heroin, and fentanyl within five High…

Eutylone intoxications: an emerging synthetic stimulant in forensic investigations

NDEWS Co-Investigator Dr. Bruce Goldberger and NDEWS Scientific Advisory Group Member Dr. Barry Logan, along with other collaborators at NMS Labs and the Center for Forensic Science Research and Education, recently published an article on the synthetic cathinone eutylone (bk-EBDB), which was identified in 83 forensic investigations from thirteen states.

Nora’s Blog: NIDA researchers adapt their projects to study COVID-19

Dr. Nora Volkow, the Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health, describes the NDEWS COVID-19 supplement in her blog post. Read more about our initiative to track substance-use-related COVID-19 consequences through local key informant interviews in all 18 sentinel sites.

The National Drug Early Warning System (NDEWS) is funded by the National Institute on Drug Abuse (U01DA051126) to the University of Florida (PI: Cottler; Co-Is: Goldberger, Nixon, Striley), New York University (Co-I: Palamar), and Florida Atlantic University (Co-I: Barenholtz).